D48 Neoplasm of uncertain behavior of other and unspecified sites

⚠ Non-Billable ICD-10-CM 2026
Create your free account → Open D48 in the app →

Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for D48.

The ICD-10-CM code for Neoplasm of uncertain behavior of other and unspecified sites is D48 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
D37-D48: Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)
Category D48
25 codes (21 billable)
FY2026 Status
Stable since FY2024
Excludes1
Not coded here. These conditions should NOT be coded together with D48.
  • neurofibromatosis (nonmalignant) (Q85.0-)

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Cite This Page

Reference D48 with the canonical source and edition:

D48 — Neoplasm of uncertain behavior of other and unspecified sites. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/D48

Canonical URL: https://icd10codingpro.com/codes/D48

Related Codes

All Codes in D48

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial